论文部分内容阅读
米拉贝隆是一种新型、有效及高选择性的β_3受体激动剂,能增加膀胱容积、降低膀胱自主收缩的频率、延长排尿间歇,进一步安全有效地控制膀胱过度活动症。临床研究证实,米拉贝隆可以显著减少24 h尿失禁次数及排尿次数并增加平均每次排尿尿液体积,在改善尿急发生和夜尿增多等方面也有很好的疗效,且具有良好的安全性和耐受性,为治疗膀胱过度活动症改善患者生活质量提供了新的治疗手段。
Mirabelon is a new, effective and highly selective β_3 receptor agonist, which can increase the volume of the bladder, reduce the frequency of spontaneous contraction of the bladder, prolong the intermittent urination and further control overactive bladder safely and effectively. Clinical studies have confirmed that Mirabelon can significantly reduce the 24-hour urinary incontinence and urination frequency and increase the average volume of urine per urine, urinary urgency and improve the incidence of nocturia also has a good effect, and has a good Safety and tolerability, provide a new treatment for the treatment of overactive bladder to improve the quality of life of patients.